🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07590362
Recruiting Observational

D-RSBI Versus RSBI for Predicting Weaning Success in COPD Patients

NCT07590362 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-04-15
Last updated
2026-05-15

Condition(s) studied

Chronic Obstructive Pulmonary Disease (COPD)Mechanical Ventilator Weaning

Study summary

This prospective observational cohort study aims to compare the predictive accuracy of diaphragmatic rapid shallow breathing index (D-RSBI) versus traditional rapid shallow breathing index (RSBI) for predicting weaning success from invasive mechanical ventilation in COPD patients. Diaphragmatic ultrasound measurements will be performed during spontaneous breathing trials, and patients will be followed for 72 hours after extubation to assess weaning outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Mechanically ventilated COPD patients fulfilling standard weaning readiness criteria. * Invasive mechanical ventilation for more than 24 hours before spontaneous breathing trial. * Hemodynamically stable without significant vasopressor support. * Adequate oxygenation with FiO2 ≤ 0.5 and PEEP ≤ 8 cmH2O . * Preserved mental status and ability to initiate spontaneous breathing. * Successful tolerance of spontaneous breathing trial conducted on CPAP mode with pressure support ≤ 8 cmH2O. Exclusion Criteria: * Refusal of consent * Neuromuscular disease, phrenic nerve palsy, or diaphragmatic paralysis. * Large pneumothorax or pathology interfering with ultrasound assessment. * Terminal extubation. * Recent major thoracic surgery. * Poor sonographic window despite repeated attempts.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sohag University Hospital Sohag Sohag Governorate Recruiting

More Sohag University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07590362 on ClinicalTrials.gov ↗ ← All trials in Egypt